Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Pearson

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
Health Affairs (Project Hope)|December 8, 2011
Can coverage be rescinded when negative trial results threaten a popular procedure? The ongoing saga of vertebroplastyKatharine Cooper Wulff, Franklin G Miller, Steven D Pearson
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2019
New Cost-Effectiveness Methods to Determine Value-Based Prices for Potential Cures: What Are the Options?Steven D Pearson, Daniel A Ollendorf, Richard H Chapman
JAMA|January 8, 2004
Physician-citizens--public roles and professional obligationsRussell L Gruen, Steven D Pearson, Troyen A Brennan
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
The Effectiveness and Value of Treatments for Spinal Muscular AtrophySteven D Pearson, Praveen Thokala, Matt Stevenson, et al.
JAMA Internal Medicine|December 15, 2015
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and ValueJeffrey A Tice, Dhruv S Kazi, Steven D Pearson
Pharmacoeconomics|July 17, 2023
An Alternative Measure of Health for Value Assessment: The Equal Value Life-YearJonathan D Campbell, Melanie D Whittington, Steven D Pearson
Neurology|January 13, 2022
Performing Cost-Effectiveness Analyses to Support Policy Making: Key Lessons From the Assessment of AducanumabJonathan D Campbell, Melanie D Whittington, Steven D Pearson
JAMA Internal Medicine|January 1, 2016
Sacubitril-Valsartan for the Treatment of Heart Failure: Effectiveness and ValueDaniel A Ollendorf, Alexander T Sandhu, Steven D Pearson
Archives of Internal Medicine|December 10, 2003
Leaving the practice: effects of primary care physician departure on patient careAnne G Pereira, Ken P Kleinman, Steven D Pearson
JAMA Internal Medicine|September 7, 2016
CardioMEMS HF for the Management of Heart Failure-Effectiveness and ValueDaniel A Ollendorf, Alexander T Sandhu, Steven D Pearson
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
Health Affairs (Project Hope)|December 8, 2011
Can coverage be rescinded when negative trial results threaten a popular procedure? The ongoing saga of vertebroplastyKatharine Cooper Wulff, Franklin G Miller, Steven D Pearson
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2019
New Cost-Effectiveness Methods to Determine Value-Based Prices for Potential Cures: What Are the Options?Steven D Pearson, Daniel A Ollendorf, Richard H Chapman
JAMA|January 8, 2004
Physician-citizens--public roles and professional obligationsRussell L Gruen, Steven D Pearson, Troyen A Brennan
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
The Effectiveness and Value of Treatments for Spinal Muscular AtrophySteven D Pearson, Praveen Thokala, Matt Stevenson, et al.
JAMA Internal Medicine|December 15, 2015
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and ValueJeffrey A Tice, Dhruv S Kazi, Steven D Pearson
Pharmacoeconomics|July 17, 2023
An Alternative Measure of Health for Value Assessment: The Equal Value Life-YearJonathan D Campbell, Melanie D Whittington, Steven D Pearson
Neurology|January 13, 2022
Performing Cost-Effectiveness Analyses to Support Policy Making: Key Lessons From the Assessment of AducanumabJonathan D Campbell, Melanie D Whittington, Steven D Pearson
JAMA Internal Medicine|January 1, 2016
Sacubitril-Valsartan for the Treatment of Heart Failure: Effectiveness and ValueDaniel A Ollendorf, Alexander T Sandhu, Steven D Pearson
Archives of Internal Medicine|December 10, 2003
Leaving the practice: effects of primary care physician departure on patient careAnne G Pereira, Ken P Kleinman, Steven D Pearson
JAMA Internal Medicine|September 7, 2016
CardioMEMS HF for the Management of Heart Failure-Effectiveness and ValueDaniel A Ollendorf, Alexander T Sandhu, Steven D Pearson
Pageof 17